相关实验视频
Updated: Feb 28, 2026
07:38
Strategies for Assessing Autistic-Like Behaviors in Mice
Published on: September 20, 2024
2.6K
在自闭症谱系障碍的新疗法
Sara Daniella Kevelson1, Rana Elmaghraby2, Fenil Patel2
1Department of Psychiatry, Weill Cornell Medicine, New York, NY 10065, USA.
概括
本综述探讨了在行为,心理药物,数字,神经调节和遗传领域的新兴自闭症谱系障碍 (ASD) 治疗方法. 挑战包括异质性和公平获取,重点是个性化,肯定神经多样性的方法.
科学领域:
- 神经发育障碍 神经发育障碍
- 治疗创新 治疗创新
- 自闭症谱系障碍 (ASD) 研究研究
背景情况:
- 自闭症谱系障碍 (ASD) 呈现出显著的异质性,使治疗开发和研究概括性复杂化.
- 目前对ASD的治疗选择缺乏全面的方法来解决其全部复杂性.
- 确定可靠的生物标志物和确保公平获得护理仍然是ASD研究的关键挑战.
研究的目的:
- 在五个关键领域批判性地评估自闭症谱系障碍 (ASD) 的新疗法.
- 确定当前ASD治疗研究中的局限性和挑战.
- 概述未来发展严格,包容和协作自闭症治疗的方向.
主要方法:
- 在行为/心理社会干预,心理药物学,数字/人工智能工具,神经调节和遗传疗法中对新型治疗方法的系统审查.
- 分析研究挑战,包括异质性,生物标志物,结果和获取.
- 评估当前的证据,局限性和ASD治疗的未来方向.
主要成果:
- 行为疗法正在向自然主义,神经多样性肯定模型发展.
- 没有FDA批准的药物用于核心ASD症状;研究重点是分层,生物知情的方法.
- 针对综合症ASD的基因向疗法的进步代表了向精准医学迈进的步伐,尽管挑战仍然存在.
结论:
- 新型ASD治疗方法在不同领域显示出前景,强调个性化和神经多样性.
- 解决异质性,开发生物标志物和确保公平获取对于未来的进步至关重要.
- 合作努力对于推进自闭症谱系障碍的严格和包容性治疗策略至关重要.
相关概念视频
01:19Autism Spectrum Disorder
1.4K
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.4K
01:26Modeling in Therapy
606
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
606
01:24Operant Conditioning Intervention
554
Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
In operant conditioning, behaviors that are...
554
01:22Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
01:28Drug Therapy
327
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
327
01:23Antidepressant Drugs: MAOIs and Other Agents
1.0K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.0K